Dr Ramli Zainal is currently the Director of National Pharmaceutical
Regulatory Agency (NPRA). Prior to the present appointment, he is the Director of Pharmacy Policy & Strategic Planning Division, Pharmaceutical Services Division (PSD) Ministry of Health Malaysia.

Dr. Ramli Zainal graduated with a degree in Pharmacy from Universiti Sains Malaysia (USM) and completed a Master’s degree from University of Bradford. He was then awarded a PhD in PharmacoEconomics from USM.

Earlier appointment includes, Head of Healthcare Economic Research Division at the Institute for Health Systems Research (IHSR) and various other positions in the National Pharmaceutical Control Bureau as a GMP Auditor, Head of Cosmetic Unit, Head of Secretariat Unit and Head of Organisational Development & IT Division. He has also worked as a Drug Enforcement Officer in Penang and as a Hospital Pharmacist.

As a researcher, Dr Ramli Zainal is the principle investigator for projects funded by UNDP and the National Institute of Health. He also collaborated in various projects and is actively involved in conducting trainings in the field of economics evaluation in healthcare. He is an expert member to the Ministry of Health Malaysia, PharmacoEconomics Technical Working Group, Health Technology Assessment group and is an appointed member of the Pharmacy Board Malaysia.

He has served the World Health Organisation (WHO) as a consultant for the Training of Trainer in QA/QI in Papua New Guinea and countries within the WHO Western Pacific Regional Office. He is also involved in the training for QA/QI at national level. He is currently the Honorary Secretary to the Malaysian Society for PharmacoEconomics and Outcomes Research (MySPOR) and a member of the Malaysian Pharmaceutical Society (MPS).

Mohd Cairul Iqbal Mohd Amin earned his BSc (Hons) in Pharmacy in 1996 and PhD in 2001 both from the University of Manchester, United Kingdom. He is currently the Deputy Leader of UKM Grand Challenge for Malaysia Health & Wellness with the responsibility to accelerate translational and high impact research in UKM. His current research interests include responsive-hydrogel biomaterials for oral protein and peptide delivery, cell delivery in tissue engineering and nano drug delivery systems in particular polymeric micellar conjugates for cancer research.

Shin Aoki obtained Ph.D. from the University of Tokyo, Japan, in 1992 and became a professor at Tokyo University of Science in 2003 after research experience at the University of Tokyo, the Scripps Research Institute, and Hiroshima University. His main researches include bioorganic, bioinorganic, medicinal, and supramolecular chemistry.

Joel Tyndall leads a research group at the University of Otago, New Zealand. He obtained his doctorate from the University of Queensland in drug design in 2000. His research involves drug discovery in the areas of cancer and infectious diseases as well as the understanding of resistance mechanisms in infectious diseases.

Chi Wi ONG obtained his doctorate from Cambridge (1983). His research focused primarily on applying chemical expertise in the area of functional group transformations and scaffold modifications for the inventive design of new biologically active molecules, especially in the field of genomics and natural products as potential anticancer agents. Other field include synthetic methodology and supramolecular chemistry.

Professor Dr. Mohamed Azmi Ahmad Hassali graduated with a Bachelor Degree in Pharmacy from Universiti Sains Malaysia in the year 1998 and a Master’s Degree in the field Clinical Pharmacy from the same university in 2001. In the year 2002, he was selected to receive the ‘Universiti Sains Malaysia Academic Staff Training Fellowship (ASTS)’ to pursue his PhD studies in the field of social pharmacy in Australia. He was successfully awarded with a PhD degree by the Victorian College of Pharmacy, Monash University, Melbourne, Australia in the year 2006.

Surakit Nathisuwan received a Doctor of Pharmacy degree (University of Florida) in 1999, Specialized Residency in Pharmacotherapy (University of Texas) and became US Board Certified Pharmacotherapy Specialist in 2001. His main area of teaching and research interest is in cardiovascular pharmacotherapy and pharmacy practice.

BPharm PhD DSc (hc); Fellow of the Royal Pharmaceutical Society; Honorary Fellow of the British Pharmacological Society. Dean, Faculty of Science, University of Strathclyde (2002-2008); Emeritus Professor of Pharmacology; Member of the Editorial Boards of Diabetes, Obesity and Metabolism and the Journal of Ethnopharmacology. Research publications in diabetes and obesity.

Professor Leong has conducted multi-year research focused on cancer biology, drug target discovery, novel molecules development, and biomarkers development for cancers. He was a Senior Research Fellow at the Harvard Medical School and Massachusetts General Hospital, USA and is presently the Deputy Director of the Institute for Research, Development and Innovation (IRDI).

Bimo Ario Tejo obtained his BSc in Chemistry from the University of Indonesia in 1999 and his PhD in Biotechnology from Universiti Putra Malaysia in 2004. He did his postdoctorate in Pharmaceutical Chemistry at the University of Kansas. He is now Dean of Faculty of Applied Sciences, UCSI University. He has almost 20 years of research experience in protein and peptide chemistry, pharmaceutical chemistry, and computational biology. He has published over 50 peer-reviewed papers, presented his work at 60 seminars and conferences, and filed 5 patents out of his work.

I obtained my doctorate from Tokyo University of Science, in Japan in 1996 and became a professor at Tokyo University of Science in 2018 after research experience at Yokohama City Univ. and Cancer Institute. My research field is signal network system in the area of cancer.

Tomomi Akita obtained Ph.D. from Tokyo University of Science, Japan, and received TUS award 2017 and Ōmura Prize in 2017. She currently is Assistant Professor at Tokyo University of Science. Her special fields are Pharmaceutics and Drug Delivery, Regenerative Medicine.

Yohei Kawano obtained Ph. D. from University of Miyazaki in 2012, and worked as pharmacist at University of Miyazaki Hospital from 2005 to 2015. Then he became a Assistant professor at Tokyo University of Science in 2016.

Mohd bin Makmor Bakry obtained his BPharm (Hons) in 1999 from UKM and PhD in 2007 from the University of Glasgow, Scotland. He was the recipient of the 11th Anugerah Akademik Negara (National Academic Award) in 2017. His current research interests include clinical pharmacy practice and pharmacotherapy in neuromedical illnesses.

Eugene obtained his PhD from Universiti Sains Malaysia in 2011 as an Asia Program Associate in RIKEN, Japan in the field of chemical biology. Then, he was a postdoctoral fellow in the Enteric Diseases Research Cluster at INFORMM, USM where he is now a senior lecturer since 2014.

Chin Fen NEOH completed her PhD at Monash University (Melbourne, Australia) and was awarded the Vice-Chancellor's Commendation for Doctoral Thesis Excellence in 2013. Her research interest is in the field of pharmacoeconomics and outcome research, specifically in infectious diseases, oncology and diabetes mellitus.

Dr Rajesh is an Associate Professor at Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, leads the Stem Cell & Immunity Research Group and Regenerative Medicine Research Program. He received bachelor’s degree in Biomedical Sciences (Immunology) and subsequently completed PhD in Stem Cell Transplantation at Imperial College of London.

Daryono Hadi Tjahjono's research interest is design and synthesis of porphyrin and chlorophyll derivatives as photosensitizer for photodynamic therapy and ligand for radiopharmaceutical, as well as their in silico and in vivo study.

A senior pharmacist at Flinders Medical Centre, a 550-bed teaching hospital in Adelaide, Australia. Cameron holds academic affiliation within the School of Pharmacy, University of South Australia and is an Honorary Research Associate in the Department of Medicine, Imperial College London. His research involves optomising the clinical use of antibiotics.

Dr. Qamar U. Ahmed obtained his BSc (Hons.), MSc and PhD (Organic Chemistry) (2002) from Aligarh Muslim University, India. He has been associated with IIUM since 2004. His current research interest is the synthesis and isolation of biologically active compounds and structure activity relationship studies with respect to discover antidiabetic, anticancer and antimicrobial agents.

Prof Winnie Chee’s research is primarily focused on the nutritional aspects of bone health, Type 2 diabetes, obesity and chronic kidney disease with the objectives to understand the nutritional determinants and interventions in the Asian context. She is currently the President of the Malaysian Dietitians’ Association. Dr Chee also provides consultation as a dietitian in the IMU Medical Clinic, Bukit Jalil, Kuala Lumpur.

Prof Chu Wan Loy is presently the Dean of the School of Postgraduate Studies, IMU and was the Deputy Director of the Institute for Research, Development and Innovation (IRDI), IMU from 2012- 2017. He also sits on the IMU Joint Committee on Research and Ethics (IMU JC). Prof Chu has been actively involved in Algal Biotechnology research for more than 20 years. Prof Chu, as an active member of the Malaysian Antarctic Research Programme (MARP) went on three expeditions to the Antarctic and Arctic. His research interests cover many aspects of algal biotechnology, ranging from bioactives and nutraceuticals (e.g. anticancer, antiviral and antioxidant compounds) from algae, applications of algae in environmental health (e.g. bioremediation and toxicity testing) to stress adaptation in tropical and polar algae. Prof Chu is presently Executive Council Member of the Asian Pacific Phycological Association (APPA) and was the Honorary Secretary of APPA from 2005-2011. He was also an Associate Member of the Academy of Sciences Malaysia (ASM) from 2012 to 2017.